Part, Chapter, Paragraph
1 II, 4. 1 | for at least the last 6 months, because of health problems (
2 II, 5. 1. 1| toddlers usually after 10 months of age.~Liver Cirrhosis~
3 II, 5. 4. 2| HbA1c tested in last 12 months~16~Percent of diabetic subjects
4 II, 5. 4. 2| lipid profile in the last 12 months~14~Percent of diabetic subjects
5 II, 5. 4. 2| subjects tested in the last 12 months with total cholesterol>5
6 II, 5. 4. 2| subjects tested in the last 12 months with LDL>2.6 mmol/l (>3
7 II, 5. 4. 2| subjects tested in the last 12 months with HDL<1.15 mmol/l (<1.
8 II, 5. 4. 2| subjects tested in the last 12 months with triglycerides >2.3
9 II, 5. 4. 2| microalbuminuria in the last 12 months~12~Percent of diabetic subjects
10 II, 5. 4. 2| microalbuminuria in the last 12 months, with an abnormal level~
11 II, 5. 4. 2| pressure measurement in last 12 months~14~Percent of of diabetic
12 II, 5. 4. 2| pressure in the last 12 months showing a value >140/90~
13 II, 5. 4. 2| inspection in the last 12 months~11~Percent of diabetic subjects
14 II, 5. 4. 2| subjects tested in the last 12 months, with proliferative retinopathy
15 II, 5. 4. 2| proliferative retinopathy in last 12 months~6~Percent of diabetic subjects
16 II, 5. 4. 2| received laser treatment<3 months after diagnosis of proliferative
17 II, 5. 4. 2| serum creatinine in last 12 months~13~Percent of diabetic subjects
18 II, 5. 4. 2| haemoglobin (HbA1c) in the last 12 months is measured as the percentage
19 II, 5. 4. 2| measured in the last 12 months. EUCID results were obtained
20 II, 5. 4. 2| cholesterol in the last 12 months is an important parameter
21 II, 5. 4. 2| cholesterol tested in the last 12 months.~Total cholesterol level>
22 II, 5. 4. 2| cholesterol tested in last 12 months showing a total cholesterol
23 II, 5. 4. 2| cholesterol in the last 12 months is another important aspect
24 II, 5. 4. 2| LDL-cholesterol tested in the last 12 months.~LDL cholesterol level >
25 II, 5. 4. 2| LDL-cholesterol tested in the last 12 months and presenting a value above
26 II, 5. 4. 2| cholesterol in the last 12 months is also taken as an indicator
27 II, 5. 4. 2| LDL-cholesterol tested in the last 12 months.~HDL cholesterol level <
28 II, 5. 4. 2| HDL-cholesterol tested in the last 12 months and HDL cholesterol below
29 II, 5. 4. 2| triglycerides in the last 12 months is the last important parameter
30 II, 5. 4. 2| triglycerides tested in the last 12 months.~Triglycerides level >2.
31 II, 5. 4. 2| cholesterol tested in last 12 months showing a total cholesterol
32 II, 5. 4. 2| proteinuria exists) in the last 12 months.~An abnormal level of albuminuria
33 II, 5. 4. 2| proteinuria tested in last 12 months with a microalbuminuria
34 II, 5. 4. 2| measured in the last 12 months. The median is 95% for Germany.
35 II, 5. 4. 2| measured in the last 12 months and reported a diastolic
36 II, 5. 4. 2| fundus inspected in last 12 months. This indicator is the only
37 II, 5. 4. 2| inspected in the last 12 months and were diagnosed with
38 II, 5. 4. 2| inspected in the last 12 months and were diagnosed with
39 II, 5. 4. 2| laser treatment within 3 months.~Control of serum creatinine
40 II, 5. 4. 2| tested during the last 12 months.~Renal failure is measured
41 II, 5. 4. 2| creatinine tested in the last 12 months and End Stage Renal Failure (
42 II, 5. 4. 3| haemoglobin (HbA1c) in the last 12 months. OECD data (Armesto et al,
43 II, 5. 4. 3| cholesterol in the last 12 months. EUCID crude data from 12
44 II, 5. 4. 3| cholesterol in the last 12 months. The EUCID indicator varies
45 II, 5. 4. 3| cholesterol in the last 12 months. The EUCID indicator varies
46 II, 5. 4. 3| triglycerides in the last 12 months. EUCID crude data from 11
47 II, 5. 4. 3| inspected in the last 12 months and were diagnosed with
48 II, 5. 5. 1| mental disorder during 12 months, ESEMeD Study.~ ~Anxiety
49 II, 5. 5. 3| from Germany from the 12-months period between July 2002
50 II, 5. 5. 3| in these surveys was 12 months (Kohn et al, 2004).~The
51 II, 5. 5. 3| discontinuation over 12 months in patients with first-episode
52 II, 5. 5. 3| between six and eighteen months of age. Some of their characteristic
53 II, 5. 5. 3| deterioration, over several months of intellectual, social
54 II, 5. 5. 3| seizures a month over 18 months or longer.~ ~
55 II, 5. 5. 3| probability of illness by 24 months was 86% in patients with
56 II, 5. 5. 3| ban)~___ __~Belgium I 12 months First unprovoked seizure (
57 II, 5. 5. 3| First unprovoked seizure (6 months)~ First seizure, idiopathic (
58 II, 5. 5. 3| First seizure, idiopathic (3 months)~ Seizures not impairing
59 II, 5. 5. 3| not impairing driving (3 months)~ Seizures during sleep,
60 II, 5. 5. 3| pattern established~ by 24 months~ II 120 months (no AED;
61 II, 5. 5. 3| established~ by 24 months~ II 120 months (no AED; First unprovoked
62 II, 5. 5. 3| seizure (2 years)~Croatia I 24 months Ban in people taking drugs
63 II, 5. 5. 3| with driving~Denmark I 12 months Seizures during sleep (license
64 II, 5. 5. 3| First unprovoked seizure (6 months)~ II 60 months (taxi 120;
65 II, 5. 5. 3| seizure (6 months)~ II 60 months (taxi 120; Must be off AED
66 II, 5. 5. 3| 240) 5 years~Estonia I 24 months -~ II - Prohibited~Finland
67 II, 5. 5. 3| Prohibited~Finland I 12 months First unprovoked seizure
68 II, 5. 5. 3| normal~ diagnostic tests (3 months)~ Sporadic seizures (6 months)~
69 II, 5. 5. 3| months)~ Sporadic seizures (6 months)~ Myoclonias (dose)~ II -
70 II, 5. 5. 3| Prohibited~France I 12 months Seizures only on awakening~
71 II, 5. 5. 3| only on awakening~ II 24-60 months No seizures in previous
72 II, 5. 5. 3| previous 3 years~Germany I 12 months Single seizures or occasion-related
73 II, 5. 5. 3| occasion-related seizures~ (3-6 months)~ First seizure, idiopathic (
74 II, 5. 5. 3| seizure, idiopathic (3-6 months)~ Treatment stop (ban 3
75 II, 5. 5. 3| Treatment stop (ban 3 months)~ II 60 months (no AED)
76 II, 5. 5. 3| stop (ban 3 months)~ II 60 months (no AED) First seizure,
77 II, 5. 5. 3| seizure, idiopathic (24 months)~Ireland I 12 months Seizures
78 II, 5. 5. 3| 24 months)~Ireland I 12 months Seizures during sleep established
79 II, 5. 5. 3| established by 1 year~Italy I 24 months -~ II - Prohibited~Netherlands
80 II, 5. 5. 3| Prohibited~Netherlands I 12 months First unprovoked seizure (
81 II, 5. 5. 3| First unprovoked seizure (6 months)~ First unprovoked, idiopathic
82 II, 5. 5. 3| unprovoked, idiopathic seizure (3 months)~ Sporadic seizures (6 months)~
83 II, 5. 5. 3| months)~ Sporadic seizures (6 months)~ Myoclonias, single partial
84 II, 5. 5. 3| single partial seizures (3 months)~ Treatment stop/change (
85 II, 5. 5. 3| Treatment stop/change (ban 3 months)~ II 60 months (no AED;
86 II, 5. 5. 3| change (ban 3 months)~ II 60 months (no AED; Untreated first
87 II, 5. 5. 3| activity)~ ~ ~Norway I 12 months Drugs stolen or last seizure
88 II, 5. 5. 3| particular~ circumstances~ II 120 months (taxi) -~Sweden I 24 months
89 II, 5. 5. 3| months (taxi) -~Sweden I 24 months Single unprovoked seizure~
90 II, 5. 5. 3| unprovoked seizure~ II 60 months (taxi) -~Switzerland I 12
91 II, 5. 5. 3| taxi) -~Switzerland I 12 months -~United Kingdom I 12 months
92 II, 5. 5. 3| months -~United Kingdom I 12 months Seizures during sleep with
93 II, 5. 5. 3| established~ by 3 years~ II 120 months (no AED) Medical examination
94 II, 5. 6. 3| a median duration of 10 months. There is also an increased
95 II, 5. 6. 3| functional outcome at 6 months (Kaukonen et al, 1988; Sernbo
96 II, 5. 6. 3| is between 6 weeks and 3 months duration and chronic when
97 II, 5. 6. 3| when it lasts more than 3 months (Frymoyer, 1988). Frequent
98 II, 5. 6. 3| with 90% returning within 2 months (Woolf and Pfleger, 2003),
99 II, 5. 6. 3| return to work. After 6 months off work, less than 50%
100 II, 5. 7. 1| persist for more than 3 months. The disease is categorized
101 II, 5. 7. 1| abnormalities of the kidneys for >3 months, as manifested by:~1. Kidney
102 II, 5. 8. 6| showed that in the last 12 months of life, decedents with
103 II, 5. 8. 7| lung cancer in the last 12 months of life. Respir Med 102:
104 II, 5. 9. FB| wheezing at the age of 3 months in breast-fed infants with
105 II, 5. 9. FB| intervention beyond 4 to 6 months of age for the development
106 II, 5. 9. FB| foods for at least four months in children has some protective
107 II, 5. 9. 3| 5.9.1. Wheeze in last 12 months in ECHRS and ISAAC phase
108 II, 5. 14. 2| within the Previous Twelve Months~Proportion of population
109 II, 5. 14. 3| within the previous twelve months~ ~In Eastern Europe, many
110 II, 6. 3. 4| may last for six to eight months, and usually with a much
111 II, 6. 3. 4| treatment for at least six months with a combination of antibiotics.
112 II, 6. 3. 6| mean survival of about 14 months. The main suspected route
113 II, 8. 1. 2| disability (LSHPD) for 6 months or more or expected to last
114 II, 8. 1. 2| more or expected to last 6 months or more. The indicator used
115 II, 9 | got drunk in the last 12 months peaks in Denmark (WHO/HSBC,
116 II, 9 | used it in the previous 12 months. Regular use of cannabis (
117 II, 9 | times in the previous 12 months) is highest (15% or over)
118 II, 9. 2. 3| more in the previous 12 months (HBSC, 2004). Unintentional
119 II, 9. 2. 4| got drunk in the last 12 months peaks in Denmark (WHO/HSBC,
120 II, 9. 2. 4| used it in the previous 12 months. Regular use of cannabis (
121 II, 9. 2. 4| times in the previous 12 months) is highest (15% or over)
122 II, 9. 2. 5| exclusive breastfeeding for six months and continued breastfeeding,
123 II, 9. 3. 1| occurred after 12 consecutive months of amenorrhea for which
124 II, 9. 3. 3| coital act during the last 12 months;~· percentage of men who
125 III, 10. 2. 1| once during the previous 12 months, and 65% had consumed alcohol
126 III, 10. 2. 1| average during the previous 12 months Table 10.2.1.2.1. The proportion
127 III, 10. 3. 1| measurement after the first six months of occupation is still recommended
128 III, 10. 3. 3| that may last up to two months or even longer. Diphtheria
129 III, 10. 3. 3| mean survival of about 14 months. The main suspected route
130 III, 10. 4. 1| population by approximately nine months, which is comparable to
131 III, 10. 4. 1| life expectancy of about 9 months for every EU citizen. Exposure
132 III, 10. 4. 2| feeding for at least four months. Solid foods should not
133 III, 10. 4. 2| residents: works started (9 months contract ongoing funded
134 III, 10. 4. 2| be slaughtered after six months of age cannot make a distinction
135 III, 10. 4. 2| it is reviewed every six months.~ ~The findings and conclusions
136 III, 10. 5. 3| absence during the previous 12 months. Furthermore, perceived
137 III, 10. 5. 3| problems at least once in 12 months (Table 10.5.3.1). This results
138 III, 10. 5. 3| their jobs in the next six months.~The economic sectors most
139 III, 10. 5. 3| their jobs in the next six months. Workers in education, health,
140 III, 10. 5. 3| his job in the next six months compared to every tenth
141 III, 10. 6. 1| members over the last 12 months. Another dimension that
142 IV, 12. 10 | breastfeeding up to four and six months of age respectively~ ~Proportion
143 IV, 12. 10 | breastfeeding up to four and six months of age respectively~ ~Domain
144 IV, 12. 10 | during the last twelve months~Domain of objective 8~ ~
